Xiaodong Li - Publications
Affiliations: | 2007 | Harvard University, Cambridge, MA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2015 | Ding B, Wang Z, Jiang X, Li X, Wang C, Zhong Q, Jiang L, Dai M, Zhang YU, Wei QI, Meng F. Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study. Molecular and Clinical Oncology. 3: 1139-1144. PMID 26623066 DOI: 10.3892/mco.2015.605 | 0.408 | |||
2015 | Sun H, Yee KL, Gill S, Liu W, Li X, Panebianco D, Mangin E, Morrison D, McCrea J, Wagner JA, Troyer MD. Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects. Journal of Psychopharmacology (Oxford, England). PMID 26464455 DOI: 10.1177/0269881115609015 | 0.426 | |||
2005 | Chen C, Li X, Neumann CS, Lo MM, Schreiber SL. Convergent diversity-oriented synthesis of small-molecule hybrids. Angewandte Chemie (International Ed. in English). 44: 2249-52. PMID 15747386 DOI: 10.1002/Anie.200462798 | 0.592 | |||
2004 | Bradner J, Kim Y, Koehler A, Kawasumi M, Li X, Schreiber SL, Nghiem P. Identification and Characterization of Novel Small-Molecule Inhibitors of the Replication Checkpoint. Blood. 104: 763-763. DOI: 10.1182/Blood.V104.11.763.763 | 0.646 | |||
2003 | Chen C, Li X, Schreiber SL. Catalytic asymmetric [3+2] cycloaddition of azomethine ylides. Development of a versatile stepwise, three-component reaction for diversity-oriented synthesis. Journal of the American Chemical Society. 125: 10174-5. PMID 12926931 DOI: 10.1021/Ja036558Z | 0.397 | |||
Show low-probability matches. |